Immune Design is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Immune Design is a company headquartered in the United States. Immune Design has been acquired. Brouky records 1 investor associated with the company.
Immune Design was an immunotherapy company that developed in vivo vaccine and therapeutic platforms to activate antigen-specific cytotoxic immune responses for cancer and infectious diseases. The company advanced clinical-stage immunotherapies and was acquired by Merck in 2019.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.